{"id":52642,"date":"2023-01-06T17:02:10","date_gmt":"2023-01-06T16:02:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/"},"modified":"2023-01-06T17:02:10","modified_gmt":"2023-01-06T16:02:10","slug":"akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/","title":{"rendered":"Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference"},"content":{"rendered":"
\n

BOSTON–(BUSINESS WIRE)–Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Biotech Showcase<\/a> and Solebury 1×1 Management Access Conference<\/a>, both happening alongside the J.P. Morgan Healthcare Conference in San Francisco next week.\n<\/p>\n

<\/a><\/p>\n

\nEddie Martucci<\/a>, Akili\u2019s Co-Founder and Chief Executive Officer, will represent the company and Digital Therapeutics Alliance (DTA)<\/a> as a panelist on the Biotech Showcase Future Panel: Digital Therapeutics in The Next Decade<\/a>, scheduled for January 11 at 12:00 p.m. (Eastern Time).\n<\/p>\n

\nCompany leaders will also meet with investors attending the J.P. Morgan Healthcare Conference.\n<\/p>\n

\nAbout Akili<\/b>\n<\/p>\n

\nAkili is pioneering the development of cognitive treatments through game-changing technologies. Akili\u2019s approach of leveraging technologies designed to directly target the brain establishes a new category of medicine \u2013 medicine that is validated through clinical trials like a drug or medical device but experienced like entertainment. Akili\u2019s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs. Driven by Akili\u2019s belief that effective medicine can also be fun and engaging, Akili\u2019s products are delivered through captivating action video game experiences. For more information, please visit www.akiliinteractive.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors:<\/b>
Joshua Young
\n
VP, Investor Relations
\n
jyoung@akiliinteractive.com<\/a>\n<\/p>\n

\nMedia:<\/b>
Susannah Wesley-Ahlschwede
\n
VP, Communications
\n
swesley@akiliinteractive.com<\/a><\/span>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BOSTON–(BUSINESS WIRE)–Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Biotech Showcase and Solebury 1×1 Management Access Conference, both happening alongside the J.P. Morgan Healthcare Conference in San Francisco next week. Eddie Martucci, Akili\u2019s Co-Founder and Chief Executive Officer, will represent the company and Digital Therapeutics Alliance (DTA) as a panelist … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52642","6":"format-standard","7":"category-industry"},"yoast_head":"\nAkili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOSTON–(BUSINESS WIRE)–Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Biotech Showcase and Solebury 1×1 Management Access Conference, both happening alongside the J.P. Morgan Healthcare Conference in San Francisco next week. Eddie Martucci, Akili\u2019s Co-Founder and Chief Executive Officer, will represent the company and Digital Therapeutics Alliance (DTA) as a panelist ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-06T16:02:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230106005313\/en\/689868\/21\/Akili_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference\",\"datePublished\":\"2023-01-06T16:02:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/\"},\"wordCount\":236,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005313\\\/en\\\/689868\\\/21\\\/Akili_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/\",\"name\":\"Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005313\\\/en\\\/689868\\\/21\\\/Akili_Logo.jpg\",\"datePublished\":\"2023-01-06T16:02:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005313\\\/en\\\/689868\\\/21\\\/Akili_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005313\\\/en\\\/689868\\\/21\\\/Akili_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference - Pharma Trend","og_description":"BOSTON–(BUSINESS WIRE)–Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Biotech Showcase and Solebury 1×1 Management Access Conference, both happening alongside the J.P. Morgan Healthcare Conference in San Francisco next week. Eddie Martucci, Akili\u2019s Co-Founder and Chief Executive Officer, will represent the company and Digital Therapeutics Alliance (DTA) as a panelist ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-06T16:02:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230106005313\/en\/689868\/21\/Akili_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference","datePublished":"2023-01-06T16:02:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/"},"wordCount":236,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230106005313\/en\/689868\/21\/Akili_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/","name":"Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230106005313\/en\/689868\/21\/Akili_Logo.jpg","datePublished":"2023-01-06T16:02:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230106005313\/en\/689868\/21\/Akili_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230106005313\/en\/689868\/21\/Akili_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/akili-to-champion-digital-therapeutics-in-conjunction-with-j-p-morgan-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52642"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52642\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}